iBio, Inc. IBIO
NASDAQ IBIO
$0.84 +0.02 (+2.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

iBio (IBIO) EV to EBITDA (2018)

Updated

iBio's (IBIO) EV to EBITDA stood at 0.82 in fiscal Q2 2019 (quarter ended Dec 31, 2018), down 10.8% from the prior quarter.

Analysis

iBio (IBIO) EV to EBITDA (2018) Analysis & Trends

On a TTM basis, iBio's EV to EBITDA came in at 0.78 as of Dec 31, 2018.

  • Quarterly EV to EBITDA has ranged from 0.57 in fiscal Q4 2018 to 1.53 in fiscal Q3 2018 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at 0.92 (Q1 2019), 0.57 (Q4 2018) and 1.53 (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 iBio 87.41 Mn -177.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 0.82
Sep 30, 2018 0.92
Jun 30, 2018 0.57
Mar 31, 2018 1.53
API Access

iBio EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=IBIO&period=max&api_key=YOUR_API_KEY